Current Pharmaceutical Design

SEP 10, 2026 · JOURNAL ARTICLE

Novel Therapeutic Frontiers in Duchenne Muscular Dystrophy: Gene Therapy, Exon Skipping, and Stem Cell Approaches

Current Pharmaceutical Design

Duchenne Muscular Dystrophy (DMD) is a chronic X-linked recessive neuromuscular disorder with a prevalence of 1 in 3,500 to 5,000 live male births worldwide. Alterations in the dys

AUG 19, 2026 · JOURNAL ARTICLE

Exploring the Potential of CRISPR-Cas9 in Carcinoma Therapy: Advances, Challenges and Future Perspectives

Current Pharmaceutical Design

This is a narrative review exploring mechanisms and prospects of CRISPR-Cas9 in cancer therapy without reporting clinical trial data, efficacy outcomes, or comparative evidence.

JUL 22, 2026 · JOURNAL ARTICLE

Harnessing Lipid-Based Nanocarriers for Skin Cancer Therapy: A Comprehensive Review of Drug Delivery, Gene-Based Strategies, and Clinical Translation

Current Pharmaceutical Design

This is a narrative review summarizing preclinical mechanisms and early translational potential of lipid nanocarriers for skin cancer, raising questions rather than answering them with clinical evidence.

JUL 17, 2026 · JOURNAL ARTICLE

In vitro and In vivo Based Multi-Target Therapy and Prognostic Bio-modeling inLiver Cancer

Current Pharmaceutical Design

This is a computational and exploratory study integrating bioinformatics, network analysis, and preliminary in vitro work to identify candidate genes and a drug target in HCC, without controlled comparison or clinical outcome data.